Harmony Gold Mining Company Limited (HMY) At $1.80 Forms Bottom; CORD BLOOD AMERICA (CBAI) Shorts Up By 352%

Harmony Gold Mining Company Limited (HMY) formed multiple bottom with $1.64 target or 9.00% below today’s $1.80 share price. Harmony Gold Mining Company Limited (HMY) has $721.34 million valuation. The stock increased 2.27% or $0.04 during the last trading session, reaching $1.8. About 1.94 million shares traded. Harmony Gold Mining Company Limited (NYSE:HMY) has declined 31.33% since January 11, 2017 and is downtrending. It has underperformed by 48.03% the S&P500.

CORD BLOOD AMERICA (OTCMKTS:CBAI) had an increase of 352% in short interest. CBAI’s SI was 22,600 shares in January as released by FINRA. Its up 352% from 5,000 shares previously. The stock increased 7.69% or $0.0002 during the last trading session, reaching $0.0028. About shares traded. Cord Blood America, Inc. (OTCMKTS:CBAI) has 0.00% since January 11, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 7 analysts covering Harmony Gold Mining (NYSE:HMY), 0 have Buy rating, 1 Sell and 6 Hold. Therefore 0 are positive. Harmony Gold Mining had 12 analyst reports since August 20, 2015 according to SRatingsIntel. The stock of Harmony Gold Mining Company Limited (NYSE:HMY) earned “Sell” rating by Deutsche Bank on Friday, March 17. As per Friday, July 1, the company rating was upgraded by Macquarie Research. Zacks upgraded Harmony Gold Mining Company Limited (NYSE:HMY) on Wednesday, August 26 to “Sell” rating. The company was downgraded on Thursday, August 20 by Zacks. As per Monday, September 14, the company rating was downgraded by JP Morgan. As per Friday, November 11, the company rating was downgraded by HSBC. The stock of Harmony Gold Mining Company Limited (NYSE:HMY) has “Equal-Weight” rating given on Friday, November 11 by Morgan Stanley. Deutsche Bank upgraded the shares of HMY in report on Thursday, November 30 to “Hold” rating. The company was downgraded on Friday, October 20 by Bank of America. The stock has “Underperform” rating by Macquarie Research on Tuesday, March 15.

Cord Blood America, Inc. provides private cord blood and cord tissue stem cell storage services to families in the United States, Puerto Rico, Argentina, Uruguay, and Paraguay. The company has market cap of $3.56 million. The firm offers services, including collection of materials, physician and customer support, transportation, and comprehensive testing. It currently has negative earnings. It also procures birth tissue for organizations utilizing the tissue in the transplantation and/or research of therapeutic based products.